公司资料
National Vision 股价、新闻与催化剂
- 股票代码:
- EYE
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
18.23 USD (+1.96%)
收盘价
最后更新: 2026年8月24日
1.31B USD
市值
股价为何变动
As of Aug 24, 2026, EYE closed up 1.96% at $18.23. No new same-company headline was identified in the current news window.
公司概览
业务概览
National Vision is a value-oriented optical retailer focused on eyecare, eyewear, and vision services.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, National Vision sits in retail healthcare rather than biotech.
商业模式特征
The business depends on store traffic, prescription demand, insurance mix, and retail execution.
生物医药行业定位
National Vision is outside biotech and belongs to consumer-health retail, where demand and execution drive the stock.
未来催化剂
- National Vision's catalysts are eye-exam traffic, insurance mix, and retail execution across its optical footprint. The company improves when the consumer and clinical sides of the business both stay healthy.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。